Cargando…

Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution

Recombinant adenovirus (rAd) vectors represent one of the most frequently used vehicles for gene transfer applications in vitro and in vivo. rAd genomes are constructed in Escherichia coli where their genomes can be maintained, propagated, and modified in form of circular plasmids or bacterial artif...

Descripción completa

Detalles Bibliográficos
Autores principales: Riedl, André, Fischer, Julian, Burgert, Hans-Gerhard, Ruzsics, Zsolt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975557/
https://www.ncbi.nlm.nih.gov/pubmed/35369433
http://dx.doi.org/10.3389/fmicb.2022.854690
_version_ 1784680389434933248
author Riedl, André
Fischer, Julian
Burgert, Hans-Gerhard
Ruzsics, Zsolt
author_facet Riedl, André
Fischer, Julian
Burgert, Hans-Gerhard
Ruzsics, Zsolt
author_sort Riedl, André
collection PubMed
description Recombinant adenovirus (rAd) vectors represent one of the most frequently used vehicles for gene transfer applications in vitro and in vivo. rAd genomes are constructed in Escherichia coli where their genomes can be maintained, propagated, and modified in form of circular plasmids or bacterial artificial chromosomes. Although the rescue of rAds from their circular plasmid or bacmid forms is well established, it works with relatively low primary efficiency, preventing this technology for library applications. To overcome this barrier, we tested a novel strategy for the reconstitution of rAds that utilizes the CRISPR/Cas-machinery to cleave the circular rAd genomes in close proximity to their inverted terminal repeats (ITRs) within the producer cells upon transfection. This CRISPR/Cas-mediated in vivo terminal resolution allowed efficient rescue of vectors derived from different human adenovirus (HAdV) species. By this means, it was not only possible to increase the efficiency of virus rescue by about 50-fold, but the presented methodology appeared also remarkably simpler and faster than traditional rAd reconstitution methods.
format Online
Article
Text
id pubmed-8975557
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89755572022-04-02 Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution Riedl, André Fischer, Julian Burgert, Hans-Gerhard Ruzsics, Zsolt Front Microbiol Microbiology Recombinant adenovirus (rAd) vectors represent one of the most frequently used vehicles for gene transfer applications in vitro and in vivo. rAd genomes are constructed in Escherichia coli where their genomes can be maintained, propagated, and modified in form of circular plasmids or bacterial artificial chromosomes. Although the rescue of rAds from their circular plasmid or bacmid forms is well established, it works with relatively low primary efficiency, preventing this technology for library applications. To overcome this barrier, we tested a novel strategy for the reconstitution of rAds that utilizes the CRISPR/Cas-machinery to cleave the circular rAd genomes in close proximity to their inverted terminal repeats (ITRs) within the producer cells upon transfection. This CRISPR/Cas-mediated in vivo terminal resolution allowed efficient rescue of vectors derived from different human adenovirus (HAdV) species. By this means, it was not only possible to increase the efficiency of virus rescue by about 50-fold, but the presented methodology appeared also remarkably simpler and faster than traditional rAd reconstitution methods. Frontiers Media S.A. 2022-03-18 /pmc/articles/PMC8975557/ /pubmed/35369433 http://dx.doi.org/10.3389/fmicb.2022.854690 Text en Copyright © 2022 Riedl, Fischer, Burgert and Ruzsics. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Riedl, André
Fischer, Julian
Burgert, Hans-Gerhard
Ruzsics, Zsolt
Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution
title Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution
title_full Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution
title_fullStr Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution
title_full_unstemmed Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution
title_short Rescue of Recombinant Adenoviruses by CRISPR/Cas-Mediated in vivo Terminal Resolution
title_sort rescue of recombinant adenoviruses by crispr/cas-mediated in vivo terminal resolution
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975557/
https://www.ncbi.nlm.nih.gov/pubmed/35369433
http://dx.doi.org/10.3389/fmicb.2022.854690
work_keys_str_mv AT riedlandre rescueofrecombinantadenovirusesbycrisprcasmediatedinvivoterminalresolution
AT fischerjulian rescueofrecombinantadenovirusesbycrisprcasmediatedinvivoterminalresolution
AT burgerthansgerhard rescueofrecombinantadenovirusesbycrisprcasmediatedinvivoterminalresolution
AT ruzsicszsolt rescueofrecombinantadenovirusesbycrisprcasmediatedinvivoterminalresolution